The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens

Arthritis and Rheumatism

Volumn 63, Issue 7, 2011, Pages 1823-1832

  Willemze, Annemiek ^a   Van Der Woude, Diane ^a   Ghidey, Wendimagegn ^a   Levarht, E W Nivine ^a   Stoeken Rijsbergen, Gerrie ^a   Verduyn, Willem ^a   De Vries, René R P ^a   Houwing Duistermaat, Jeanine J ^a   Huizinga, Tom W J ^a   Trouw, Leendert A ^a   Toes, René E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ENOLASE; EPITOPE; FIBRINOGEN; MYELIN BASIC PROTEIN; VIMENTIN;

ADULT; ALLELE; ARTICLE; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN M; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SMOKING;

EID: 79959824881     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30409     Document Type: Article

References (39)

1. Van Venrooij WJ, Van Beers JJ, Pruijn GJ,. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci 2008; 1143: 268-85.
2. Nielen MM, Van der Horst AR, Van Schaardenburg D, Van der Horst-Bruinsma IE, Van De Stadt RJ, Aarden L, et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005; 64: 1199-204. (Pubitemid 41113357)
3. Rantapaa-Dahlqvist S, De Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9. (Pubitemid 37280601)
4. Van Gaalen FA, Linn-Rasker SP, Van Venrooij WJ, De Jong BA, Breedveld FC, Verweij CL, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004; 50: 709-15. (Pubitemid 38326168)
5. Ioan-Facsinay A, el-Bannoudi H, Scherer HU, Van der Woude D, Menard HA, Lora M, et al. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis 2011; 70: 188-93.
6. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 961-73.
7. Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engstrom A, et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009; 206: 449-62.
8. Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, et al. Induction of macrophage secretion of tumor necrosis factor α through FcÎ receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 2008; 58: 678-88. (Pubitemid 351364865)
9. Schuerwegh AJ, Ioan-Facsinay A, Dorjee AL, Roos J, Bajema IM, Van der Voort EI, et al. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis. Proc Natl Acad Sci U S A 2010; 107: 2586-91.
10. Trouw LA, Haisma EM, Levarht EW, Van der Woude D, Ioan-Facsinay A, Daha MR, et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 2009; 60: 1923-31.
11. Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L,. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008; 26: 651-75. (Pubitemid 351600388)
12. Van der Helm-van Mil AH, Huizinga TW,. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008; 10: 205.
13. Gregersen PK, Silver J, Winchester RJ,. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13. (Pubitemid 18005792)
14. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, De Vries RR,. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1117-21. (Pubitemid 43672924)
15. Vossenaar ER, Despres N, Lapointe E, Van der Heijden A, Lora M, Senshu T, et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004; 6: R142-50.
16. Schellekens GA, De Jong BA, Van den Hoogen FH, Van De Putte LB, Van Venrooij WJ,. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81. (Pubitemid 28058927)
17. Verpoort KN, Cheung K, Ioan-Facsinay A, Van der Helm-van Mil AH, De Vries-Bouwstra JK, Allaart CF, et al. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum 2007; 56: 3949-52. (Pubitemid 350262321)
18. Van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, De Vries RR, Toes RE,. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum 2007; 56: 425-32.
19. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, Van der Helm-van Mil AH, et al, for the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study group. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007; 80: 867-75. (Pubitemid 46668455)
20. Linn-Rasker SP, Van der Helm-van Mil AH, Van Gaalen FA, Kloppenburg M, De Vries RR, le Cessie S, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006; 65: 366-71. (Pubitemid 43268227)
21. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A,. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-9. (Pubitemid 41126030)
22. Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, De Vivo I, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010; 69: 54-60.
23. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41: 1319-24.
24. Van der Woude D, Alemayehu WG, Verduijn W, De Vries RR, Houwing-Duistermaat JJ, Huizinga TW, et al. Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis. Nat Genet 2010; 42: 814-6.
25. De Rooy DP, Van der Linden MP, Knevel R, Huizinga TW, Van der Helm-van Mil AH,. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2011; 50: 93-100.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
27. Van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schreuder GM, et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999; 60: 152-8. (Pubitemid 29072099)
28. Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, Van der Woude D, et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 2008; 58: 3000-8.
29. Boire G, Cossette P, De Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, et al. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Arthritis Res Ther 2005; 7: R592-603.
30. Koivula MK, Heliovaara M, Ramberg J, Knekt P, Rissanen H, Palosuo T, et al. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis. Ann Rheum Dis 2007; 66: 1450-5. (Pubitemid 350032651)
31. Tilleman K, Van Beneden K, Dhondt A, Hoffman I, De Keyser F, Veys E, et al. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics 2005; 5: 2247-57. (Pubitemid 40770586)
32. Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, et al. Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R1421-9.
33. Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006; 36: 2250-63. (Pubitemid 44251769)
34. Van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 2010; 69: 1554-61.
35. Skrondal A,. Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol 2003; 158: 251-8. (Pubitemid 36944418)
36. Rothman KJ,. Measuring interactions. Epidemiology: an introduction. New York: Oxford University Press; 2002. p. 173-6.
37. Damjanovska L, Thabet MM, Levarth EW, Stoeken-Rijsbergen G, Van der Voort EI, Toes RE, et al. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis 2010; 69: 730-2.
38. Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006; 65: 1219-22. (Pubitemid 44277400)
39. Demidenko E,. Sample size and optimal design for logistic regression with binary interaction. Stat Med 2008; 27: 36-46. (Pubitemid 351193658)